Global Cell Expansion Market, by Product (Consumables, (Media, Others), Instruments (Automated Cell, Expansion Systems, Cell Counters, Centrifuges, Bioreactors, Others), Accessories), by Cell Type (Mammalian Cells, (Human Cells, Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells), Differentiated Cells, Animal Cells), Microbial Cells, Others (Plant-derived Cells)), by Application (Biopharmaceuticals, Tissue Culture & Engineering, Vaccine Production, Drug Development, Cancer Research, Stem Cell Research, Other Applications), by End User (Biotechnology Companies, Biopharmaceutical Companies, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 16,035.5 million in 2022 and is expected to exhibit a CAGR of 11.8% during the forecast period (2022-2030).

Market players adopting strategies such as agreements to accelerate development of cell therapies is expected to drive the growth of global cell expansion market, over the forecast period. For instance, in February 2022, Fluidigm Corporation, an advanced biotechnology products supplier with a mission to enhance people's lives via holistic health insights, announced a collaboration agreement with the Abu Dhabi Stem Cells Center (ADSCC) for the development of targeted stem cell therapies and research applications using two Fluidigm mass cytometry and tissue imaging technologies: Imaging Mass Cytometry and the Maxpar Direct Immune Profiling Assay.

Market players operating in this market are offering systems ideal for perfusion based cell culture expansion, is expected to drive the growth of global cell expansion market. For instance, Cytiva, a subsidiary of Danaher Corporation, offers ReadyToProcess WAVE 25 Rocker. The ReadyToProcess WAVE 25 single-use rocking bioreactor system is a reliable and simple cell culture solution for working volumes up to 25 L. The system uses a well-known rocking technology to mix and aerate the culture, which is kept in an inflated, disposable Cellbag bioreactor cultivation chamber. It has a built-in perfusion filter. It also features predetermined perfusion methods in the system's control software, making it simple to operate.

Research institutes are receiving funds to research and develop new products related to cell therapies, this is expected to boost the growth of global cell expansion market, over the forecast period. For instance, in October 2019, Southwest Research Institute (SwRI) announced that it received  funding from the Medical Technology Enterprise Consortium (MTEC) and the U.S. Food and Drug Administration (FDA) to expand cells for customized regenerative medicine applications using a bioreactor created by SwRI. A US$ 3 million MTEC program will show stem cell manufacturing, while a US$ 2.3 million U.S. FDA contract will fund the development of Chimeric antigen receptor (CAR) T cells.

Global Cell Expansion Market - Impact of Coronavirus (COVID – 19) Pandemic

The coronavirus disease (COVID-19) pandemic is expected to hamper the growth of the global cell expansion market, over the forecast period. COVID-19 is the recent pandemic outbreak, which was first reported on December 31, 2019 in Wuhan, China. The World Health Organization declared coronavirus disease (COVID-19) as a pandemic on March 11, 2020. According to the World Health Organization (WHO) Weekly epidemiological update on COVID-19, the number of new cases decreased during the week of September 4, 2022. Therefore, as of September 4, 2022, 600 million confirmed cases and 6.4 million deaths have been reported globally.

Lockdown or shutdown was imposed in several countries due to the COVID-19, which had a negative impact on the economy of the private healthcare sector. This lockdown resulted in the closure of industrial establishments, except manufacturing of essential commodities, and disruption in the supply chain of products. Furthermore, players operating in the global cell expansion market are facing major challenges on various fronts due to the COVID-19 pandemic. The major challenges include supply of raw materials required for manufacturing instruments and accessories used in cell expansion applications along with irregularities in transportation facility.

Browse 39 Market Data Tables and 42 Figures spread through 402 Pages and in-depth TOC on Global Cell Expansion Market, by Product (Consumables, (Media, Others), Instruments (Automated Cell, Expansion Systems, Cell Counters, Centrifuges, Bioreactors, Others), Accessories), by Cell Type (Mammalian Cells, (Human Cells, Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells), Differentiated Cells, Animal Cells), Microbial Cells, Others (Plant-derived Cells)), by Application (Biopharmaceuticals, Tissue Culture & Engineering, Vaccine Production, Drug Development, Cancer Research, Stem Cell Research, Other Applications), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa).

To know the latest trends and insights prevalent in the Cell Expansion Market, click the link below:

https://www.coherentmarketinsights.com/market-insight/cell-expansion-market-1293

Market players are involved in the inorganic growth activities such as partnership, is expected to drive the global cell expansion market. For instance, in March 2020, Applikon Biotechnology B.V., a Dutch upstream bioprocess equipment expert, announced a partnership with Sotelab of Brazil, one of Latin America's major suppliers and distributors of laboratory and life sciences equipment. Applikon's innovative cultivation systems will have a stronger presence in South America owing to a partnership with Sotelab, situated in Rio de Janeiro.

Key Takeaways of the Global Cell Expansion Market:

  • The global cell expansion market is expected to exhibit a CAGR of 11.8% over the forecast period (2022-2030), owing to growth in potential markets, especially in Europe. While North America accounted for the major market share.
  • The rising burden of chronic diseases such as diabetes, cancers, and others increases the demand for cell therapy for the treatment of patients suffering from these diseases. Such factors are expected to drive the demand for cell therapy, and in turn, drive the market growth in this region. For instance, according to Globocan (World Health Organization), in 2020, there were 1.1 million new cases of cancer and approximately 700 thousand deaths caused by cancer in Africa.
  • Major players operating in the global cell expansion market include Becton, Dickinson and Company, Sartorius AG, Merck KGaA, Corning, Inc., Eppendorf SE, Lonza Group AG, PromoCell, Danaher, Thermo Fisher Scientific, HiMedia Laboratories, STEMCELL Technologies Inc., REPROCELL Inc., Bio-Techne, Valiant Co., Ltd., Miltenyi Biotec, Biologos, Cyagen US Inc.

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo